WO2025079083A1

WO2025079083A1 - Respiratory disease related patient health management ecosystem

Info

Publication number: WO2025079083A1
Application number: PCT/IN2024/051945
Authority: WO
Inventors: Preetish Mohan TORASKAR; Nandita Sumit DANDEKAR; Ira Preetish TORASKAR
Original assignee: Pink Tree Health LLP
Current assignee: Pink Tree Health LLP
Priority date: 2023-10-14
Filing date: 2024-10-03
Publication date: 2025-04-17
Anticipated expiration: 2026-04-14
Also published as: WO2025079083A9

Abstract

Respiratory disease related patient health management ecosystem is described wherein a phygital platform (1) for the management of acute and chronic respiratory illnesses is provided. Said platform (1) comprises a user interface (100), a healthcare professional module (300a), a patient module (300b) and a caregiver module (300c). It acts as a constant intelligent non-intrusive interface between the healthcare professional and the patient. The respiratory health of the patient is monitored with the aid of home medical testing devices (400b) and answers to a set of standard questionnaires (400a). On a daily basis the information is retrieved and analysed by the server to generate lung health score which is transmitted to the healthcare professional module (300a) for evaluation. Based on the score of the individual patient, directions are sent to the patient module (300b) or caregiver module (300c) in case minors and golden agers avoid life threatening circumstances.

Description

TITLE: RESPIRATORY DISEASE RELATED PATIENT HEALTH MANAGEMENT

ECOSYSTEM

FIELD OF INVENTION

The present invention relates to the field of healthcare management. More particularly, the present invention relates to an ecosystem in the form of a phygital (digital+physical) platform to enable the remote monitoring of the progression of different respiratory diseases for individual patients and its effective management.

BACKGROUND OF THE INVENTION

Chronic respiratory diseases and infections are among the most common conditions worldwide. Millions of people are affected with obstructive pulmonary diseases like Tuberculosis, Bronchial asthma, Sleep Apnea and COPD (Chronic obstructive pulmonary disease). The disease condition goes out of control due to ignorance of the symptoms and lack of proper knowledge. It is advantageous for the elderly, the sick and small children to have their lung function monitored for fitness and wellbeing reasons, or when they are in places with high levels of ground ozone, smog, or other air pollutants.

The common line of medication includes daily or twice-daily administration of bronchodilator and/or anti-inflammatory medications. Metered dose inhalers are also frequently used to administer these medications by inhalation. But, the overuse of inhalers can lead to potentially fatal adverse effects which include raised blood pressure, cardiac arrest, immune-suppression, caustic damage, and/or tissue scarring. Additionally, excessive use of the inhaler often indicates the need for a more hard-line therapy, like oral administration of corticosteroid; if this need is ignored and the inhaler is still overused, the risk of asthma-related death rises.

It's critical to regularly monitor both the use of inhalers and symptoms; there shall be a system that will help to prevent overuse of inhalers and improve daily management of lung health. It's also critical to monitor inhaler use and symptoms in conjunction with other lung and airway conditions, such as chronic bronchitis, emphysema, cystic fibrosis, and chronic obstructive pulmonary disease (COPD).

Another problem associated with these chronic diseases is the low adherence rate to the therapy. As per WHO reports, adherence rates are generally lower for chronic disease vs acute diseases, as adherence decreases with time. Current average non-compliance to therapy is 30-40%. As per reports, improved adherence rates with use of reminders can go up from 46% up to 73%.

Frequent hospital visits and medical consultations are vital for the effective management of any respiratory diseases. The conventional way of consulting health care professionals includes a hospital visit, standing in a long queue for registration, waiting for the health care professional and availing medicine from the pharmacy. Considering these difficulties, the patients tend to avoid the routine visits to their healthcare professionals.

But it is to be noted that, currently all stakeholders in the chronic healthcare space operate in isolation. The health care professional and the patient meet each other infrequently, maybe once or twice in a year, and have very little scope of interacting with each other with tangible and measurable mechanisms between these visits. This means that the health care professional is unaware of the patient’s health status between these visits. According to a general observation, most of the people and the working communities often tend to skip the scheduled hospital visits. This leads to the worsening of their disease conditions.

Additionally, patients’ visit to the health professionals is irregular with a frequency of once in a year or once in six months resulting in disconnect between patient and health professionals. There is no track of the health of the patients by health professionals. This results in treatment of visible symptoms rather than proactive management of the conditions.

Recently, tele-medicine has emerged as one of the effective alternatives for the remote delivery of healthcare services. It allows healthcare providers to evaluate, diagnose and treat patients without an in-person visit. This possibility was largely explored during the COVID pandemic. Moreover, technology has advanced in such a way that some of the clinical analysis like blood glucose level, blood pressure or heart rate can be performed at home itself, either alone or with the help of health care professionals. With the development of wireless communication, mobile computing and internet of things, various mobile health applications have evolved. Using these Apps, users can modify their lifestyle and maintain a good health condition. Such Apps are a boon to those who are affected with certain specific disease conditions. Whenever the values exceed the normal range, they can sense the danger and immediately consult a health care professional. However, most of the Apps are restricted to monitoring of normal health conditions, and there are only very few Apps available that are specially designed to monitor a specific disease.

The need of the hour is to have a common platform which brings the stakeholders such as patient, healthcare professional together to monitor the severe condition of the disease and manage them lung health of the patient proactively to avoid any casualties. The present invention provides a patient health management ecosystem for the remote monitoring of the progression of respiratory diseases.

OBJECTS OF THE INVENTION

The primary object of the present invention is to provide a respiratory disease related patient health management ecosystem in the form of a phygital platform for the effective management of respiratory diseases.

Another object of the present invention is to provide a phygital platform for the regular monitoring of respiratory illness.

Yet another object of the present invention is to provide a system to improve quality of life in case of the patients with respiratory diseases.

Yet another object of the present invention is to provide a platform for on-time health care professional-patient communication, medication management and involvement of health care providers to ensure optimal health outcomes.

Further object of the present invention is to provide a constant intelligent non-intrusive interface between the health care professional and the patient between the two physical visits to avoid the probable casualties.

Yet further object of the present invention is to provide a patient educator platform, wherein the patient is guided and supported on a real time basis.

Further object of the present invention is to provide a platform where both physical and virtual events are conducted that will have unique objectives of focusing directly or indirectly on respiratory health improvement of the patients. Yet another object of the present invention is to offer an online and offline platform for the patients to attend events related to education, recreation, awareness, competitive, social, or rehabilitation areas for respiratory health management.

Yet another object of the present invention is to build a platform to minimize the difficulties and expenses related to hospital visits.

SUMMARY OF THE INVENTION

This section is provided to introduce certain objects and aspects of the present disclosure in a simplified form that are further described below in the detailed description. This summary is not intended to identify the key features or the scope of the claimed subject matter.

Embodiments of the present disclosure may relate to a system and a method of a respiratory disease related patient health management ecosystem in the form of a phygital platform.

Embodiments of the present disclosure describes a respiratory disease related patient health management ecosystem in the form of a phygital platform comprising a server with a lung health score calculator, user interface, stakeholders’ modules and testing means. The stakeholders’ modules are made of individual modules for all the stakeholders such as Patient module, health professional module and caregiver module. These modules enable the respective stakeholders to stay connected on this common phygital platform and proactively manage the health status of the lungs. The healthcare professional’s module enables the healthcare professional to take decisions and decide the line of treatment for the particular patient. The Patient’s module needs to be operated by the patient by selecting option for specific disease and undergoing a set of tasks to routinely feed the up-to-date information about the disease conditions by way of testing means which include answering a standardized pre-defined questionnaire and carrying out certain office tests for the specific disease he is suffering from. The caregiver module is provided to aid the disease management of the minors and golden agers. The caregiver follows the line of treatment decided by the healthcare professional. The phygital platform of the present invention is also equipped with a lung health score calculator that helps in calculation of lung health score based on the answers of the questionnaire and the office tests taken by the patient.

The respiratory disease related patient health management ecosystem embodies the tasks selected but not limited to Chronic Airways Assessment Test (CAAT), set of questionnaires, record regarding dosage frequency of Short Acting Beta Agonist (SABA) medicine, and common office test including spirometry test.

Further, the embodiments of the present disclosure encompass a method of managing the respiratory disease using the phygital platform of the said invention comprising of retrieving user data, subjecting the retrieved user data to artificial intelligence, classifying the patients based on the lung health score, transmitting the generated score to the user associated healthcare professional and receiving treatment recommendations based on the generated score.

The collected data is mapped with reference to the Aadhar or Abha card of the user. The respiratory disease related patient health management ecosystem tracks parameters like respiratory rate, peak flow parameters, FEV1, etc. on a daily and weekly basis by providing disease specific questionnaires to the user. The respiratory disease related patient health management ecosystem offers a user-friendly home-based medical evaluation to access the status of the respiratory system anytime.

BRIEF DESCRIPTION OF THE DRAWINGS

The objects, features and advantages of the present invention will be best understood from the following exemplary accompanying drawings. These drawings, which are incorporated herein, and constitute a part of this disclosure, illustrate exemplary embodiments of the disclosed system and method of managing the respiratory illnesses using a phygital platform.

FIG. 1 is a realistic representation of the phygital platform of present invention to enable patients focus on their lung health.

FIG. 2 is the schematic representation elaborating the object of the phygital platform made available for health professionals, patients and caregivers.

FIG. 3 is a schematic representation of the phygital platform described in the present invention.

FIG. 4A and 4B depicts the procedural stages of the operation of said phygital platform of the present invention.

FIG. 5A to 5D displays the disease specific tests conducted by the patient to determine the lung health score respectively for diseases Asthma, COPD, TB and Sleep Apnea.

FIG. 6A to 6G shows graphical representation of the data obtained in a survey conducted to check the preferred choice of the phygital platform by the stakeholder. FIG. 7 depicts a holistic approach of the phygital platform involving all stakeholders keeping the patient in focus.

DETAILED DESCRIPTION OF THE INVENTION

Before the present invention is described, it is to be understood that this invention is not limited to particular methodologies described, as these may vary as per the person skilled in the art. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. As used herein, the singular forms "a", "an" and "the" are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms "comprises" or "comprising," when used in this specification, specify the presence of stated features, integers, steps, operations, elements, or components, but do not preclude or rule out the presence or addition of one or more other features, integers, steps, operations, elements, components, or groups thereof. The process steps, method steps, protocols, or the like may be described in a sequential order, such processes, methods, and protocol may be configured to work in alternate orders. In other words, any sequence or order of steps that may be described does not necessarily indicate a requirement that the steps be performed in that order. The steps of processes described herein may be performed in any order practical. Further, some steps may be performed simultaneously, in parallel, or concurrently. The aim of this specification is to describe the invention without limiting the invention to any one embodiment or specific collection of features. A person skilled in the relevant art may realize the variations from the specific embodiments that will nonetheless fall within the scope of the invention, and such variations are deemed to be within the scope of the current invention. It may be appreciated that various other modifications and changes may be made to the embodiment described without departing from the spirit and scope of the invention.

Before the present invention is described, it is to be understood that this invention is not limited to particular methodologies described, as these may vary as per the person skilled in the art. It is also to be understood that the terminology used in the description is for the purpose of describing the particular embodiments only and is not intended to limit the scope of the present invention.

Throughout this specification, the word “comprises”, or variations such as “comprises” or “comprising”, will be understood to imply the inclusion of a stated element, integer or step, or group of elements, integers or steps, but not the exclusion of any other element, integer or step, or group of elements, integers or steps. The use of the expression “at least” or “at least one” suggests the use of one or more elements or ingredients or quantities, as the use may be in the embodiment of the invention to achieve one or more of the desired objects or results.

This will be readily apparent to those skilled in the art, the present invention may easily be produced in other specific forms without departing from its essential characteristics. The present embodiments are, therefore, to be considered as merely illustrative and not restrictive, the scope of the invention being indicated by the claims rather than the foregoing description, and it will be appreciated that many variations in detail are possible without departing from the scope and spirit of the invention and all such variations therefore intended to be embraced therein.

In the following description, for the purposes of explanation, various specific details are set forth in order to provide a thorough understanding of embodiments of the present disclosure.

It will be apparent, however, that embodiments of the present disclosure may be practiced without these specific details. Several features described hereafter can each be used independently of one another or with any combination of other features. An individual feature may not address any of the problems discussed above or might address only one of the problems discussed above. Some of the problems discussed above might not be fully addressed by any of the features described herein. Example embodiments of the present disclosure are described below, as illustrated in various drawings in which like reference numerals refer to the same parts throughout the different drawings.

Reference will now be made in detail to embodiments of the invention, one or more examples of which are illustrated in the drawings. Each example is provided by the explanation of the invention and not meant as limitation of the invention, e.g. features illustrated or described as part of one embodiment to yield a third embodiment. It is intended that the present invention includes these and other modifications and variations. The various types of respiratory ailments and the pulmonary function tests which are different and specific to those respiratory ailments shall not limit the scope of the invention.

The system in the present invention aims to manage lung health by keeping the patient at the centre of the care. It describes an ecosystem that is built around the patient and has features like personalized care, customized treatment plan taking into consideration the severity level of disease. Respiratory illnesses such as asthma, COPD, Tuberculosis etc. are chronic disorders that affect a staggering population of 358 million people worldwide. In these respiratory diseases the airways of an individual’s lungs constrict in response to specific stimuli. The contraction may occur due to the inflammation of the airways, excessive mucus secretion into the airways, or constriction of the muscles that surround the airways, causing the airways to become narrow. Patients with respiratory illness are prone to acute attacks, which can manifest as tightness in the chest, coughing, wheezing, and shortness of breath. An individual’s oxygen supply may become so severely restricted during severe attacks that they need emergency help. A person usually recovers fully after an acute attack with the right care. Nearly 70% of the total patient population affected with respiratory diseases is struggling to keep the disease under control.

Daily or twice-daily administration of bronchodilator and/or anti-inflammatory medications is a common treatment strategy. Metered dose inhalers are frequently used to administer these medications by inhalation.

Overuse of inhalers can lead to potentially fatal adverse effects which include raised blood pressure, cardiac arrest, immune-suppression, caustic damage, and/or tissue scarring. Additionally, excessive use of the inhaler often indicates the need for a more hard-line therapy, like oral administration of corticosteroid; if this need is ignored and the inhaler is still overused, the risk of asthma-related death rises.

Another point of concern is the lower adherence rate to the prescribed medication by the patient. As per WHO report currently average non-compliance rate with the prescribed therapy stands at 30-40%. This lack of adherence and seeking medical attention only, when necessary, leads to ill management of the condition by the patient independently. Many patients underestimate their disease leading to poor adherence to the medication and compromised quality of life.

As a result, it’s critical to regularly monitor both the use of inhalers and symptoms; this will help to prevent overuse of inhalers and improve daily management of lung health. It’s also critical to monitor inhaler use and symptoms in conjunction with other lung and airway conditions, such as chronic bronchitis, emphysema, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). It may also be advantageous for the elderly, the sick and small children to have their lung function monitored for fitness and wellbeing reasons, or when they are in places with high levels of ground ozone, smog, or other air pollutants. Despite the need, current options for monitoring asthma, other pulmonary conditions are limited. For example, asthma patients often lack exact data on the frequency or duration of their asthma attacks and the frequency of their medication administration.

Additionally, patients’ visit to the health professionals is irregular with a frequency of once in a year or once in six months resulting in disconnect between patient and health professionals.

There is no track of the health of the patients by health professionals. This results in treatment of visible symptoms rather than proactive management of the conditions.

Globally, it is the need to have a universal platform to connect patients suffering through respiratory diseases and health care professionals in order to maintain lung health as depicted in an indicative drawing FIG. 1.

Considering the above problems and severities associated with such mishandling of the disease, the present invention tries to offer a solution that addresses all the challenges by providing health professionals with regular updates on patients’ health status fostering continuous connectivity between the visits as shown in FIG. 2, Thus, present invention leads to effective disease management for the patient and enhanced patient care for the health professionals. Thus, the present invention aims at managing lung health on a universal level.

The present invention offers an everyday monitor system in the form of a phygital platform that manages the conditions of respiratory lung health and a method to provide real time insights into a patient’s health. In a digitally connected world, this invention offers a unique phygital experience, blending physical and digital realms to enhance a patient’s health.

Various embodiments disclosed herein are directed to the phygital platform of present invention to monitor and manage lung function and respiratory conditions. Embodiments of the present invention describe systems that monitor the frequency and severity of chronic attacks leading to acute pain in the patients with respiratory conditions. Also, these embodiments described herein are contemplated, and intended, for use by individuals of all ages who suffer from asthma or other respiratory conditions and are sensitive to poor air quality and weather conditions. The systems disclosed herein are configured to provide information to health professionals, patients and caregivers in order to improve the personalization of treatment and the predictability of respiratory symptom attacks. One of ordinary skill in the art of respiratory health medicine will appreciate that while some embodiments disclosed herein are directed to the monitoring and treatment of asthma for the sake of simplicity of the description, all such embodiments may also be used to monitor and manage chronic obstructive pulmonary disease (COPD), tuberculosis and sleep apnoea or other respiratory conditions.

Table 1

The present invention is a comprehensive solution based on scientific evidence in the field of respiratory health in the form of a phygital platform for proactive evidence-based disease Management of Patients to be used by healthcare professionals and relevant healthcare stakeholders.

The phygital platform has a comprehensive list of features that covers complete disease management of the relevant lung disease which the patient can monitor between their two physical visits to the healthcare professionals. Said phygital platform not only captures and collects data but also analyses this data and converts it into decision making analytics for the healthcare professionals.

Longitudinal data such as clinical, demographic, environmental, socioeconomic etc. is collected from individual patients. Said data is ingested into a statistical model to predict health outcomes for an individual patient suffering from above mentioned respiratory diseases. In this way artificial intelligence through machine learning is employed and used to forecast health events for the patient. Complex technical and scientific data points are transformed into a simple score for healthcare professionals to interpret the dynamic health status of the patient and facilitate him/her to change/continue interventions for better health outcomes. It also acts as a useful aid for healthcare professionals to counsel their patients to understand their health status and adhere/ comply well with the personalized recommendations that are prescribed.

The respiratory disease related patient health management ecosystem as described in FIG. 3 comprises a phygital platform (1) having components such as a server (100) with lung health score calculator (100a) which calculates lung health score (100b) with the assistance of Al and ML. A user interface (200), stakeholders modules (300) comprising healthcare professional module (300a) used by healthcare professionals, patient module (300b) used by patients and caregiver module (300c) used by caregivers in case of minors and golden agers. All the stakeholders are connected to each other and a user interface (200) that enables said stakeholders to interact on said phygital platform (1). Additionally, said phygital platform (1) operates in the verticals such as pharmacy, pharmaceutical companies, diagnostic laboratories and insurance firms etc., all converging to the common object of creating a throbbing ecosystem which enables the lung health management of the patient. The phygital platform (1) of the present invention enables the patients to update health status on a daily basis. Testing means (400) are provided to aid this. Said testing means (400) include a set of predefined questionnaires (400a) and testing device (400b). The testing means (400) are meant to be disease specific with the help of which disease parameters like respiratory rate, peak flow parameters, FEV1, etc. are tracked on a daily and weekly basis. The patients’ responses to the questionnaire and results of the test are fed to said lung health score calculator (100a) using Al and ML which calculate the lung health score.

Based on the lung health score value, patients are categorized into different zones to determine the criticality of the patient’s as high (Red), medium (Yellow) and low (green). The data collected is mapped with reference to the Aadhar or Abha card of the patient. This data has tremendous relevance for the patient in the near- and long-term future. The data is analyzed, interpreted in the form of lung health score and used by all the stakeholders for various purposes. The healthcare professional decides line of treatment based on the lung health score data which is conveyed to the patient or caregivers if the patients are minor or golden agers. The method of managing patients’ health as shown in FIG. 4 A to 4B using said phygital platform between two physical consultations with the healthcare professional comprising the steps of:

Receiving data from the patient via patient module (300b) and caregiver via caregiver module (300c) about health status in the form of information based on responses to disease specific standardized questionnaire (400a) and test results obtained from carrying out the disease specific office tests using said testing device (400b); storing said received data; analyzing said data received feeding it to the lung health score calculator (100a) to calculate lung health score (100b) based on which the patients are categorized in appropriate zone such as red zone for severe disease conditions, yellow indicating medium severity and green zone indicating stable disease conditions; monitoring said lung health score and zone category of said patient the line of treatment is decided by said healthcare professional and updated it on the said phygital platform (1) via said healthcare professional module (300a); the caregivers or patients use the information on the line of treatment and follow the same to prevent the criticality. The data collected is mapped with the Aadhar card or Aabha card of the patient.

EXAMPLE 1

Management of Asthma: The present invention describes a phygital platform (1) to monitor and manage asthma as shown in FIG. 5 A. The method of managing patients’ health using said phygital platform between two physical consultations with the healthcare professional involves the following steps:

Health status data is received from the asthma patients via patient module (300b) or caregiver via caregiver module (300c) in the form of spirometry test result carried out using testing device (400b) and information based on responses to disease specific standardized questionnaire (400a), this data is stored in the system and analyzed by Al and ML to calculate lung health score (100b) using lung health calculator (100a) which categorizes patients to appropriate zone. The healthcare professional gets notified about the patient zone on the said healthcare professional module (300a) and line of treatment is decided by the healthcare professional and this information is updated in said phygital platform (1). The line of treatment is followed by patients and caregivers to manage the disease conditions.

EXAMPLE 2 In this example as shown in FIG. 5B, management of COPD is described. The data of spirometry test carried out using a testing device (400b) and responses of standardized questionnaires (400a) are retrieved, stored, analyzed by Al and ML and lung health score (100b) is generated using lung health calculator (100a). The lung health score (100b) categorizes patients to appropriate zones. The lung score is transmitted to the healthcare professional module (300a) and line of treatment is provided by the healthcare professional based on the zone and the information is updated in said phygital platform (1) and made available to be seen on patient module (300b) and caregiver module (300c). The line of treatment is referred to be followed by the patient or caregiver.

EXAMPLE 3

In this example as shown in FIG. 5C patients’ BMI index using the specific device (400a) and specific questionnaires (400b) responses for TB are retrieved, stored, analyzed, fed to the lung health score calculator (100a) to calculate the lung health score (100b) is generated. Based on the appropriate zone as per lung health score the healthcare professional prescribed the line of treatment to the patient (300b) via said phygital platform (1). The lung score is transmitted to the healthcare professional module (300a) and line of treatment is provided by the healthcare professional based on the zone and the information is updated in said phygital platform (1) and made available to be seen on patient module (300b) and caregiver module (300c). The line of treatment is referred to be followed by the patient or caregiver.

EXAMPLE 4

FIG. 5D illustrates the management of sleep Apnea by said phygital platform (1). Patient’s BMI index responses based on the results of the appropriate testing device (400a) and responses of specific questionnaires (400a), data is retrieved, stored fed to said lung health score calculator (100a) to calculate the lung health score (100b). Based on the appropriate zone as per lung health score the healthcare professional prescribed the line of treatment to the patient via said phygital platform (1). The lung score is transmitted to the healthcare professional module (300a) and line of treatment is provided by the healthcare professional based on the zone and the information is updated in said phygital platform (1) and made available to be seen on patient module (300b) and caregiver module (300c). The line of treatment is referred to be followed by the patient or caregiver.

DETAILED DESCRIPTION OF DRAWINGS FIG.1 displays the need of the global lung health care using the phygital platform of the present invention i.e. Global lung health management.

FIG.2 depicts the real purpose of said phygital platform which is to offer the support to the patient between two physical consultations thereby preventing severities.

FIG. 3 is the pictorial representation of the phygital platform displaying its components namely a server, a user interface with lung health score calculator, stakeholders’ modules which are healthcare professional module, a patient module and a caregiver module (in case of minors and golden agers).

FIG.4A depicts the entire process flow of the data in the phygital platform of the present invention wherein the Patient regularly checks his health status by answering the standardized questionnaire which will calculate lung health score.

FIG. 4B depicts the decision of the line of treatment by the healthcare professional based on the lung score and the zone category decided by said lung health score which is made available on the said platform which is referred to the patient and caregiver.

FIG. 6A to 6G shows graphical representation of the data obtained in a survey conducted to check the preferred choice of the phygital platform by the stakeholder.

FIG. 7 illustrates futuristic holistic approach involving all stakeholders such as healthcare professionals, hospitals, diagnostic laboratories, pharmaceutical companies, pharmacies, insurance companies keeping the patient in focus. It also indicates the comprehensive lung health solution which aids in better patient management through its unique features. It also indicates strategies and plans of pharma companies prepared for the patient.

ADVANTAGES OF THE PRESENT INVENTION

The present invention provides many advantages, few are listed out below:

1) The present invention provides an ecosystem in the form of a phygital platform for the management of respiratory diseases, by providing a platform for periodical monitoring of clinical parameters that lead to the progression of the diseases.

2) The Ecosystem is an integrated solution to improve respiratory care. 3) The present invention helps in the management of respiratory diseases by improving the adherence rate to therapy by providing support to the patients between two consecutive consultations with his healthcare professionals.

4) The present invention provides an ecosystem that enables the users to easily assess the status of the respiratory diseases anytime.

5) The invention provides a home-based medical evaluation with a connected device that covers the health parameters of the patient voluntarily as well as involuntarily which is converted into analytics by use of Al and Machine learning. Based on the daily analytics received in the app, the healthcare providers can make recommendations.

6) The present invention helps in the constant maintenance of healthcare professional patient interaction and healthcare professionals can prescribe any additional tests based on the report generated. The healthcare providers are thus kept updated regarding the patient's health status.

6) The proposed invention creates an ecosystem around the patient involving clinicians, medical stores, diagnostic labs, insurance, pharma companies, and hospitals ensuring an effective patient support system.

7) The proposed invention reduces the number of hospital visits and associated expenses as early detection of the progression of the diseases is made possible.

8) The proposed invention provides a patient educating platform, wherein the patient will be guided and supported on a real-time basis.

9) The proposed invention provides a platform that conducts events for patients, both physical and virtual, which have unique objectives and focus directly or indirectly on improving respiratory health of the patients. These events could be educational, recreational, awareness, competitive, social, or rehabilitative in nature.

10) The proposed invention yields a patient support system that keeps evaluating/monitoring the respiratory health of patients with the aid of home medical devices, and transfers the information to the AI/ML cloud to analyze and create a unique score for every patient for the day that categorizes the patient into appropriate zones. The red zone indicates the high level of severity, yellow zone indicates medium level of severity and green zone indicates low level i.e. stable level of disease conditions. This information is shared to the healthcare professional for him to have a view of the respiratory health status of the patients. The interface thus acts as a constant intelligent, non-intrusive interface between the healthcare professional and the patient between the two physical visits.

11) The proposed invention is economically beneficial to the patient in the long run as it may reduce the chances of hospitalization and related expenses.

INVENTIVE STEP OF THE INVENTION

To underpin the problems associated with the patients suffering from respiratory diseases and to avoid the probable situations of casualty taking a toll on the life of the patients, the present invention has been scientifically derived and carefully transformed into a well-crafted technology which requires a combination of technical knowledge and innovative skills. Some of the features that make the proposed invention novel and inventive are disclosed below:

1) The present invention provides a patient health management ecosystem related to respiratory diseases.

2) The conventional systems available only capture and collect the data to store it in the cloud, whereas the present invention offers a platform that analyses this data and converts into decision making analytics for the healthcare professionals.

3) The present invention enables collection of longitudinal data from patients which is subjected to artificial intelligence through machine learning and used to forecast health events for the patient.

4) The present invention offers a solution that helps in better disease management for the patient and better patient management for the healthcare professional by maintaining the interaction of healthcare professionals with patients between two consecutive consultations, thus assisting the healthcare professionals to be equipped with the proactive line of treatment.

We Claim:

1. A respiratory disease related patient health management ecosystem in form phygital platform (1) comprising: a) Server (100) with a lung health score calculator (100a) to calculate lung health score (100b); b) User interface (200); c) stakeholder modules (300) wherein said modules (300) include: i) a healthcare professional module (300a) used by healthcare professionals, ii) a patient module (300b) used by patients, iii) a caregiver module (300c) used by caregivers in case of minors and golden agers and d) testing means (400) wherein said testing means (400) includes: i) a predefined set of questionnaires (400a) and ii) testing device (400b) specific to the respiratory disease associated with said patient.

2. The respiratory disease related patient health management ecosystem as claimed in claim 1, wherein said testing device (400b) includes common office testing device for conducting tests selected from but not limited to spirometry test, BMI check, activity report, sleep analysis, side effect profile, symptom tracker and medicine tracker.

3. A method of respiratory disease related patient health management ecosystem comprising the steps of: i) retrieving patient data related to clinical parameters associated with a respiratory disease based on disease specific standardized questionnaire (400a); ii) capturing the test results of the tests undergone by the patient from the testing device (400b); iii) feeding the data obtained from the test results and the data based on the answers to standardized questionnaire (400a) to the lung health score calculator (100a) and iv) subjecting it to analysis based on artificial intelligence through machine learning to generate a lung health score (100b) indicative of the user’s respiratory health status; v) classifying the patients based on the lung health score (100b) in specific zones;

Claims

vi) updating the zone information on the said phygital platform (1) and making it available on said healthcare professional module (300a); vii) deciding the line of treatment and providing recommendations by the healthcare professional based on the zone information; viii) updating the line of treatment decided by the health professional to said platform (1) and making it available for patient (300b) and caregiver module (300c); vii) following the line of treatment by the patients and caregivers for maintaining the health of the patient to avoid severity.

4. The method as claimed in claim 3, wherein said questionnaire (400a) of said phygital platform enables tracking of parameters like respiratory rate, peak flow parameters, FEV1, etc. on a daily and weekly basis by providing disease specific questionnaire (400a) to the Stakeholders (300).